...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Td waterhouse

,,hummm,these rumors or guesstimates come from talking with deep pocket investors for one thing,,,,they come from analysts,,,,,,they come from other posters,,,,,they even come from senior management touting sale is imminent,,,,,they come from all different sources,,,,,dont we have analysts putting target pricing on stocks all the time,,,guesstimates,,,,,even buyout pricing!

 

 

 

Share
New Message
Please login to post a reply